Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.05
Ask:
17.95
Spread: 0.90 (5.279%)
Market Cap: £22.12m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Director/PDMR Shareholding

31 Jul 2024 14:35

RNS Number : 6382Y
Cirata PLC
31 July 2024
Β 

31 July 2024

Β 

Cirata plc

("Cirata" or the "Company")

PDMR/PCA Dealings

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Β 

Cirata plc (LSE: CRTA) provides the following notification of a share transfer by a person discharging managerial responsibilities ("PDMR").

Β 

OnΒ 29 July 2024, MrΒ Kenneth Lever, Non-Executive Chairman of Cirata, transferred 245,454 Ordinary Shares of 10 pence each in the capital of Cirata to his wife Mrs Denise Lever for nil consideration (the "Share Transfer").

Β 

Following the Share Transfer, MrΒ Kenneth Lever's beneficial interest remains unchanged at 245,454 Ordinary Shares, representing approximately 0.2% per cent of the Company's issued share capital. For the purposes of the Market Abuse Regulation, this figure includes those Ordinary Shares held by Mrs Denise Lever as a "person closely associated" with MrΒ Kenneth Lever.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in respect of the Share Transfer is included at the end of this announcement.

Β 

Β 

Β 

For further information, please contact:Β 

Β 

Cirata

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Ben Good

Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / Edward Mansfield / John More

Β 

Β 

About Cirata

Β 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated.

Β 

For more information aboutΒ Cirata, visitΒ www.cirata.com

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kenneth Lever

2

Reason for the notification

a)

Position/status

PDMR - Non-Executive Chairman Β 

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cirata plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

Β 

Β 

Β ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Transfer of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β Nil consideration

Β 245,454

Β 

d)

Aggregated information

Β 

Β  n/a

Β 

e)

Date of the transaction

29 July 2024

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Denise Lever

2

Reason for the notification

a)

Position/status

PCA of PDMR - Wife of Kenneth Lever Β 

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cirata plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

Β 

Β 

Β ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Transfer of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β Nil consideration

Β 245,454

Β 

d)

Aggregated information

Β 

Β  n/a

Β 

e)

Date of the transaction

29 July 2024

f)

Place of the transaction

Outside a trading venue

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBXGDRSXXDGSB
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Return
20th May 20267:00 amRNSResult of AGM
5th May 20267:00 amRNSHolding(s) in Company
23rd Apr 20268:52 amRNSAmendment to Notice of Annual General Meeting
21st Apr 20267:00 amRNSGrant of Awards & PDMR Dealing
14th Apr 20267:00 amRNSTrading Statement
31st Mar 20263:39 pmRNSManagement Changes
31st Mar 20267:00 amRNSPreliminary Results
4th Feb 20268:54 amRNSGrant of Awards & PDMR Dealing
14th Jan 20267:00 amRNSQ4 FY25 Trading Update
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
1st Dec 20259:35 amRNSBlock Listing Return
27th Nov 20257:00 amRNSFinancial Conduct Authority Update
17th Nov 20257:00 amRNS$6.7m Multiyear Contract win
27th Oct 202510:05 amRNSNotification of Major Holdings
16th Oct 20257:00 amRNSTrading Statement
13th Oct 20257:00 amRNS$3.1m Multiyear Contract with leading US Insurer
12th Sep 202511:02 amRNSGrant of Awards & PDMR Dealing
10th Sep 20257:00 amRNSNotification of Major Holdings
9th Sep 20258:00 amRNS-RCirata launches new data platform
3rd Sep 20257:00 amRNSInterim results
13th Aug 20257:00 amRNSGrant of Share Options to PDMRs
11th Aug 20257:00 amRNSCompletion of DevOps Divestment
15th Jul 20257:07 amRNSQ2 and H1FY25 Trading Update
30th Jun 20257:01 amRNSHolding(s) in Company
30th Jun 20257:00 amRNS$700K Multiyear Data Integration Contract Renewal
10th Jun 20257:00 amRNSBoard Appointment
3rd Jun 20252:39 pmRNSBlock Listing Return
8th May 20254:47 pmRNSResult of AGM
29th Apr 202511:44 amRNSGrant of Share Options to PDMRs
16th Apr 20257:00 amRNSQ1FY25 Trading Statement
8th Apr 20257:00 amRNSAnnual Report & Notice of AGM
2nd Apr 20253:51 pmRNSNotification of Major Holdings
31st Mar 20257:01 amRNSContract win
31st Mar 20257:00 amRNSPreliminary Results
27th Feb 20257:00 amRNSNew logo in Telecom sector
20th Feb 20257:00 amRNSTotal Voting Rights
20th Jan 20256:29 pmRNSPDMR dealings and Total Voting Rights
9th Jan 20257:00 amRNSQ4FY24 Trading Update
16th Dec 20247:00 amRNSContract Win and FY24 Guidance
13th Dec 20243:46 pmRNSVesting of Restricted Stock & Director Dealings
11th Dec 20247:00 amRNSIssue of Equity
9th Dec 20247:00 amRNSMarvell Contract Renewal
2nd Dec 20243:40 pmRNSBlock Listing Return
1st Nov 20247:00 amRNSGrant of Share Options to PDMRs
24th Oct 20247:00 amRNSPDMR Transactions
9th Oct 20247:00 amRNSQ3 Trading Update and Outlook
2nd Oct 20243:19 pmRNSAmendment of OEM sales partnership with IBM
1st Oct 20247:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.